Skip to main content
Azitra, Inc. logo

Azitra, Inc. — Investor Relations & Filings

Ticker · AZTR ISIN · US05479L2034 US Manufacturing
Filings indexed 196 across all filing types
Latest filing 2023-07-24 Director's Dealing
Country US United States of America
Listing US AZTR

About Azitra, Inc.

https://azitrainc.com/

Azitra, Inc. is a clinical-stage biopharmaceutical company focused on precision dermatology. The company leverages its expertise in the skin microbiome, genetic engineering, and proteomics to develop novel treatments for skin diseases. Its therapeutic approach involves creating engineered proteins and live biotherapeutic products (LBPs). The product pipeline includes ATR-12, an engineered microbe (S. epidermidis) for Netherton syndrome; ATR-04 for EGFR inhibitor-associated rash; and ATR-01, a protein candidate for ichthyosis vulgaris.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2023-07-24 English
PRIMARY DOCUMENT
Director's Dealing
2023-07-24 English
Regulatory Filings 2023
Regulatory Filings
2023-07-11 English
Regulatory Filings 2023
Regulatory Filings
2023-07-07 English
SC 13D
Major Shareholding Notification
2023-07-03 English
Director's Dealing 2023
Director's Dealing
2023-06-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.